Roy Oliver Bähr
Geboren:
1973
Hat mitgewirkt an:
-
Multidrug-resistance-Proteine in humanen malignen Gliomen : Expression, funktionelle Aktivität und Regulation durch p53
-
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial
-
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy